Published in Respir Med on December 20, 2007
Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res (2013) 1.86
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol (2013) 1.51
Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD. Int J Chron Obstruct Pulmon Dis (2011) 1.35
Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness. Curr Allergy Asthma Rep (2011) 1.28
Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine (2012) 1.18
Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulm Med (2013) 1.11
Asthma in the elderly: what we know and what we have yet to know. World Allergy Organ J (2014) 1.10
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population. Lung India (2014) 1.06
Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease. Can J Hosp Pharm (2012) 1.04
Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res (2014) 0.92
The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy (2013) 0.91
A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol. Implement Sci (2012) 0.91
Inhaler device technique can be improved in older adults through tailored education: findings from a randomised controlled trial. NPJ Prim Care Respir Med (2014) 0.90
Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging (2013) 0.90
Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv (2014) 0.88
Study of Proper use of Inhalational Devices by Bronchial Asthma or COPD Patients Attending a Tertiary Care Hospital. J Clin Diagn Res (2014) 0.87
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med (2011) 0.87
Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study. BMC Pulm Med (2015) 0.86
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend. Am Health Drug Benefits (2014) 0.86
Self-management behaviors in older adults with asthma: associations with health literacy. J Am Geriatr Soc (2014) 0.85
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study. NPJ Prim Care Respir Med (2015) 0.85
Recent educational interventions for improvement of asthma medication adherence. Asia Pac Allergy (2012) 0.83
Evaluation of inhaler techniques among asthma patients seen in Nigeria: an observational cross sectional study. Ann Med Health Sci Res (2014) 0.83
Skills in handling turbuhaler, diskus, and pressurized metered-dose inhaler in korean asthmatic patients. Allergy Asthma Immunol Res (2010) 0.83
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD. J Asthma Allergy (2011) 0.82
Evaluating inhaler use technique in COPD patients. Int J Chron Obstruct Pulmon Dis (2015) 0.82
Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients. J Aerosol Med Pulm Drug Deliv (2013) 0.82
Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients. Int J Clin Pract (2013) 0.81
Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung. J Aerosol Med Pulm Drug Deliv (2016) 0.81
The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Effects of Educational Interventions for Chronic Airway Disease on Primary Care. J Korean Med Sci (2016) 0.81
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res (2013) 0.80
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma (2016) 0.80
Effectiveness of computerized clinical decision support systems for asthma and chronic obstructive pulmonary disease in primary care: a systematic review. BMC Pulm Med (2014) 0.80
A review of the value of innovation in inhalers for COPD and asthma. J Mark Access Health Policy (2015) 0.80
Exploring the role of quantitative feedback in inhaler technique education: a cluster-randomised, two-arm, parallel-group, repeated-measures study. NPJ Prim Care Respir Med (2014) 0.79
Impact of patient characteristics, education and knowledge on emergency room visits in patients with asthma and COPD: a descriptive and correlative study. BMC Pulm Med (2009) 0.79
Effect of inhaler design variables on paediatric use of dry powder inhalers. PLoS One (2014) 0.79
Switching treatments in COPD: implications for costs and treatment adherence. Int J Chron Obstruct Pulmon Dis (2015) 0.78
Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD. Drugs R D (2013) 0.77
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®). J Aerosol Med Pulm Drug Deliv (2014) 0.77
The Effect of Training Inhalation Technique with or without Spacer on Maximum Expiratory Flow Rate and Inhaler Usage Skills in Asthmatic Patients: A Randomized Controlled Trial. Int J Community Based Nurs Midwifery (2014) 0.77
A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions. Clinicoecon Outcomes Res (2016) 0.77
Validation of scores of use of inhalation devices: valoration of errors. J Bras Pneumol (2015) 0.77
Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older. Int J Chron Obstruct Pulmon Dis (2014) 0.77
A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.77
The assessment of new drugs for asthma and COPD: a Delphi study examining the perspectives of Italian payers and clinicians. Multidiscip Respir Med (2016) 0.75
Pharmacokinetic studies for proving bioequivalence of orally inhaled drug products-critical issues and concepts. Front Pharmacol (2015) 0.75
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv (2015) 0.75
Evaluation of proficiency in using different inhaler devices among intern doctors. J Family Med Prim Care (2016) 0.75
Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respir Med (2016) 0.75
Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler). BMJ Open Respir Res (2016) 0.75
Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance. Patient Prefer Adherence (2016) 0.75
The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries. BMC Health Serv Res (2016) 0.75
Commonly Prescribed Medications Among Patients in Hospice Care for Chronic Obstructive Pulmonary Disease. Am J Hosp Palliat Care (2015) 0.75
Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®). Patient Prefer Adherence (2016) 0.75
Efficacy of an educational intervention in primary health care in inhalation techniques: study protocol for a pragmatic cluster randomised controlled trial. Trials (2016) 0.75
Critical errors found during metered dose inhaler technique demonstration by Pharmacists. Saudi Pharm J (2015) 0.75
Study protocol for a randomized, controlled trial comparing the efficacy of two educational interventions to improve inhalation techniques in patients with chronic obstructive pulmonary disease (COPD): TIEPOC Study. Drugs Context (2014) 0.75
Benefit of educational feedback for the use of positive expiratory pressure device. Braz J Phys Ther (2015) 0.75
Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax(®) compared with Turbuhaler(®) in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain. Clinicoecon Outcomes Res (2017) 0.75
A nurse-led intervention study: Promoting compliance with Diskus Inhaler use in asthma patients. Nurs Open (2014) 0.75
A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices. NPJ Prim Care Respir Med (2016) 0.75
Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med (2017) 0.75
Need of education for dry powder inhaler storage and retention - a patient-reported survey. Multidiscip Respir Med (2016) 0.75
Educational interventions to improve inhaler techniques and their impact on asthma and COPD control: a pilot effectiveness-implementation trial. J Bras Pneumol (2017) 0.75
Evaluation of the community pharmacist's behavior towards a prescription of antidiabetic and antiasthma drugs. Pharm Pract (Granada) (2011) 0.75
Pitfalls associated with the therapeutic reference pricing practice of asthma medication. BMC Pulm Med (2012) 0.75
Do Face-to-Face Training and Telephonic Reminder Improve Dry Powder Inhaler Technique in Patients with COPD? Int J Telemed Appl (2017) 0.75
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study. BMC Pulm Med (2016) 0.75
Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin. AAPS J (2015) 0.75
Inhaler Technique in Asthma: How Does It Relate to Patients' Preferences and Attitudes Toward Their Inhalers? J Aerosol Med Pulm Drug Deliv (2016) 0.75
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma. BMC Pulm Med (2016) 0.75
Prerequisites for a dry powder inhaler for children with cystic fibrosis. PLoS One (2017) 0.75
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol (2005) 4.67
Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology (2014) 3.22
Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol (2007) 2.93
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.21
Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.09
Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis. Lancet (2005) 2.07
CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat Med (2010) 2.07
Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy. Nat Clin Pract Rheumatol (2007) 1.57
Acute physiologic effects of nasal and full-face masks during noninvasive positive-pressure ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease. Respir Care (2003) 1.57
The ADMIT series - issues in inhalation therapy. 1) The goals of asthma treatment: can they be achieved? Prim Care Respir J (2007) 1.54
P2X7 receptor-induced death of motor neurons by a peroxynitrite/FAS-dependent pathway. J Neurochem (2013) 1.52
The ADMIT series - issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir J (2010) 1.51
Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. J Bacteriol (2009) 1.40
Phosphine poisoning in a German office. Lancet (2002) 1.39
The ADMIT series--issues in inhalation therapy. 2. Improving technique and clinical effectiveness. Prim Care Respir J (2009) 1.34
Insights into oxidative stress: the isoprostanes. Curr Med Chem (2007) 1.32
Mycobacterium riyadhense sp. nov., a non-tuberculous species identified as Mycobacterium tuberculosis complex by a commercial line-probe assay. Int J Syst Evol Microbiol (2009) 1.31
Facilitating the recruitment of minority ethnic people into research: qualitative case study of South Asians and asthma. PLoS Med (2009) 1.24
The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. Prim Care Respir J (2010) 1.23
Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel. Biomaterials (2011) 1.17
IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med (2014) 1.14
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet (2011) 1.12
The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease. Dtsch Arztebl Int (2016) 1.12
Retracted Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J Clin Invest (2011) 1.10
Directed evolution of an enantioselective epoxide hydrolase: uncovering the source of enantioselectivity at each evolutionary stage. J Am Chem Soc (2009) 1.10
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. Int J Antimicrob Agents (2009) 1.04
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. Eur Respir Rev (2014) 1.04
IL-1 beta and TNF-alpha regulation of the adenosine receptor (A2A) expression: differential requirement for NF-kappa B binding to the proximal promoter. J Immunol (2006) 1.03
Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med (2006) 1.02
Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France. Emerg Infect Dis (2010) 1.00
Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Respir Med (2009) 0.99
The ADMIT series--issues in inhalation therapy. 5) Inhaler selection in children with asthma. Prim Care Respir J (2010) 0.99
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Dietary zinc alters early inflammatory responses during cutaneous wound healing in weanling CD-1 mice. J Nutr (2004) 0.96
Management of allergic problems in primary care: time for a rethink? Prim Care Respir J (2005) 0.95
Constructing and analyzing the fitness landscape of an experimental evolutionary process. Chembiochem (2008) 0.94
The ADMIT series--Issues in Inhalation Therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique. Prim Care Respir J (2011) 0.93
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma. Chest (2013) 0.93
Maternal exposure to air pollution before and during pregnancy related to changes in newborn's cord blood lymphocyte subpopulations. The EDEN study cohort. BMC Pregnancy Childbirth (2011) 0.92
Intralobar sequestration associated with cystic adenomatoid malformation: diagnostic and thoracoscopic pitfalls. Surg Endosc (2008) 0.91
Many pathways in laboratory evolution can lead to improved enzymes: how to escape from local minima. Chembiochem (2012) 0.91
Time course of diaphragm function recovery after controlled mechanical ventilation in rats. J Appl Physiol (1985) (2013) 0.90
An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg (2006) 0.89
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis. Respir Med (2009) 0.89
Cytokines in atopic diseases: revisiting the Th2 dogma. Eur J Dermatol (2006) 0.89
In vitro activity of thioridazine against mycobacteria. Int J Antimicrob Agents (2009) 0.89
Phenotypes of asthma revisited upon the presence of atopy. Respir Med (2005) 0.88
Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey. Eur Respir J (2013) 0.88
Knocking down Cav1 calcium channels implicated in Th2 cell activation prevents experimental asthma. Am J Respir Crit Care Med (2010) 0.88
T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation (2007) 0.87
Central aortic wire confirmation for emergent endovascular procedures: As fast as surgeon-performed ultrasound. J Trauma Acute Care Surg (2015) 0.87
Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis (2008) 0.87
Otomastoiditis caused by Mycobacterium abscessus, The Netherlands. Emerg Infect Dis (2010) 0.86
Metabolism and disposition of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, in healthy human subjects. Drug Metab Dispos (2011) 0.86
Polymer--drug conjugates as nano-sized medicines. Curr Opin Biotechnol (2011) 0.86
Proteasome inhibition improves diaphragm function in an animal model for COPD. Am J Physiol Lung Cell Mol Physiol (2011) 0.86
Preventing asthma exacerbations: what are the targets? Pharmacol Ther (2011) 0.86
Protection by dietary zinc in ALS mutant G93A SOD transgenic mice. Neurosci Lett (2005) 0.85
Deletion of FoxN1 in the thymic medullary epithelium reduces peripheral T cell responses to infection and mimics changes of aging. PLoS One (2012) 0.85
Creation of an amino acid network of structurally coupled residues in the directed evolution of a thermostable enzyme. Angew Chem Int Ed Engl (2009) 0.85
Expression of prostaglandin E(2) receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge. J Allergy Clin Immunol (2004) 0.83
Dynamic hyperinflation after metronome-paced hyperventilation in COPD--a 2 year follow-up. Respir Med (2010) 0.82
Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think? Respiration (2002) 0.82
Predicting nocturnal hypoventilation in hypercapnic chronic obstructive pulmonary disease patients undergoing long-term oxygen therapy. Respiration (2010) 0.82
Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma. Respir Med (2007) 0.82
Shedding light on the efficacy of laboratory evolution based on iterative saturation mutagenesis. Mol Biosyst (2008) 0.81
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease. Eur J Clin Invest (2013) 0.81
Validity of Oxycon Mobile in measuring inspiratory capacity in healthy subjects. Clin Physiol Funct Imaging (2010) 0.81
Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Respirology (2006) 0.81
Enhancing the efficiency of directed evolution in focused enzyme libraries by the adaptive substituent reordering algorithm. Chemistry (2012) 0.80
Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease. BMC Public Health (2009) 0.80
DNA/amphiphilic block copolymer nanospheres reduce asthmatic response in a mouse model of allergic asthma. Hum Gene Ther (2012) 0.80
Can a health forecasting service offer COPD patients a novel way to manage their condition? J Health Serv Res Policy (2010) 0.80
Prediction of chronic lung allograft dysfunction: a systems medicine challenge. Eur Respir J (2014) 0.79
Associations of muscle depletion with health status. Another gender difference in COPD? Clin Nutr (2010) 0.79
Do children who move home and school frequently have poorer educational outcomes in their early years at school? An anonymised cohort study. PLoS One (2013) 0.79
Inhaler devices - from theory to practice. Respir Med (2013) 0.79
Living with severe allergy: an Anaphylaxis Campaign national survey of young people. Clin Transl Allergy (2013) 0.79
Asthma caused by peracetic acid-hydrogen peroxide mixture. J Occup Health (2007) 0.79
Extreme synergistic mutational effects in the directed evolution of a baeyer-villiger monooxygenase as catalyst for asymmetric sulfoxidation. J Am Chem Soc (2014) 0.78
Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4. Respir Res (2011) 0.78
Interprofessional education in palliative care: a pilot project using popular literature. J Interprof Care (2006) 0.78
Effectiveness of quetiapine for the management of aggressive psychosis in the emergency psychiatric setting: a naturalistic uncontrolled trial. Int J Psychiatry Clin Pract (2005) 0.78
Prognostic role of clusterin in resected adenocarcinomas of the lung. Lung Cancer (2012) 0.78
Suitability of a new antimicrobial aminosterol formulation for aerosol delivery in cystic fibrosis. J Antimicrob Chemother (2011) 0.78
Inhaler choice and inhalation technique: key factors for asthma control. Prim Care Respir J (2009) 0.77
Exercises commonly used in rehabilitation of patients with chronic obstructive pulmonary disease: cardiopulmonary responses and effect over time. Arch Phys Med Rehabil (2010) 0.77
Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trial. Clin Drug Investig (2012) 0.77
Implantable carotid sinus stimulator for the treatment of resistant hypertension: local effects on carotid artery morphology. Ann Vasc Surg (2009) 0.77
An interprofessional rural clinical placement pilot project. J Interprof Care (2010) 0.77
Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms. Transplantation (2016) 0.76
Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients. J Heart Lung Transplant (2006) 0.76
Control of ventilation, breathlessness perception and alexithymia in near-fatal asthma. J Asthma (2006) 0.76
The article by Daley-Yates et al. Clin Ther (2010) 0.75
Issues in inhalation therapy: a new series of papers from the ADMIT Working Group. Prim Care Respir J (2007) 0.75
Aerosol delivery devices. Chest (2006) 0.75